| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 1,979 | 1,785 | 1,242 | 1,897 |
| Loss on sale of business | -63 | - | - | - |
| Gain on investment securities, net | 66 | 13 | 2 | 10 |
| Equity in net losses | -88 | -62 | -43 | -57 |
| Stock-based compensation | 193 | 110 | 49 | 153 |
| Depreciation | 587 | 396 | 200 | 682 |
| Amortization | 43 | 30 | 15 | 46 |
| Impairment of property and equipment | 14 | 14 | 9 | 129 |
| Impairment of indefinite-lived intangible assets | 32 | 32 | - | - |
| Receivables | -16 | 1,800 | 1,755 | 109 |
| Other assets | 1,374 | 658 | 686 | -258 |
| Benefits payable | -351 | 620 | 1,011 | 884 |
| Other liabilities | 1,317 | 1,010 | 193 | -498 |
| Unearned revenues | 5 | 14 | 5 | -71 |
| Other | 27 | 0 | 7 | 76 |
| Net cash provided by operating activities | 2,573 | 1,602 | 331 | 3,494 |
| Proceeds from sale of business, net | 115 | - | - | - |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired | 5 | 1 | 0 | 37 |
| Purchases of property and equipment, net | 344 | 209 | 95 | 421 |
| Purchases of investment securities | 5,198 | 1,941 | 827 | 6,403 |
| Proceeds from maturities of investment securities | 2,148 | 1,617 | 889 | 2,214 |
| Proceeds from sales of investment securities | 5,066 | 1,243 | 522 | 1,758 |
| Changes in securities lending collateral receivable | 141 | 48 | 175 | - |
| Net cash provided by (used in) investing activities | 1,641 | 661 | 314 | -2,889 |
| Payments from contract deposits, net | 1,164 | 579 | 35 | 638 |
| Proceeds from issuance of senior notes, net | 1,481 | 1,481 | 1,481 | 2,232 |
| Repayments of senior notes | 771 | 771 | - | 48 |
| Repayments from issuance of commercial paper, net | -5 | -5 | -4 | -895 |
| Repayment of term loan | - | - | - | 0 |
| Debt issue costs | 5 | 5 | 3 | 7 |
| Change in book overdraft | -95 | -105 | -33 | 3 |
| Common stock repurchases | 109 | 109 | 9 | 768 |
| Dividends paid | 321 | 214 | 108 | 323 |
| Changes in securities lending payable | 141 | 48 | 175 | - |
| Changes in rebate factor payable | -123 | -123 | -68 | - |
| Other | -76 | -62 | -12 | 261 |
| Net cash used in financing activities | -1,047 | -444 | 1,384 | -183 |
| Increase in cash and cash equivalents | 3,167 | 1,819 | 2,029 | 422 |
| Cash and cash equivalents at beginning of period | 2,221 | 2,221 | 2,221 | 4,694 |
| Cash and cash equivalents at end of period | 5,388 | 4,040 | 4,250 | 5,116 |
HUMANA INC (HUM)
HUMANA INC (HUM)